Evolutionary Conservation of Vertebrate Blood–Brain Barrier Chemoprotective Mechanisms in Drosophila
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Pharmacologic remedy of many brain diseases is difficult because of the powerful drug exclusion properties of the blood–brain barrier (BBB). Chemical isolation of the vertebrate brain is achieved through the highly integrated, anatomically compact and functionally overlapping chemical isolation processes of the BBB. These include functions that need to be coordinated between tight diffusion junctions and unidirectionally acting xenobiotic transporters. Understanding of many of these processes has been hampered, because they are not well mimicked by ex vivo models of the BBB and have been experimentally difficult and expensive to disentangle in intact rodent models. Here we show that the Drosophila melanogaster(Dm) humoral/CNS barrier conserves the xenobiotic exclusion properties found in the vertebrate vascular endothelium. We characterize a fly ATP binding cassette (ABC) transporter, Mdr65, that functions similarly to mammalian xenobiotic BBB transporters and show that varying its levels solely in the Dm BBB changes the inherent sensitivity of the barrier to cytotoxic pharmaceuticals. Furthermore, we demonstrate orthologous function between Mdr65 and vertebrate ABC transporters by rescuing chemical protection of the Dm brain with human MDR1/Pgp. These data indicate that the ancient origins of CNS chemoprotection extend to both conserved molecular means and functionally analogous anatomic spaces that together promote CNS selective drug partition. Thus,Dm presents an experimentally tractable system for analyzing physiological properties of the BBB in an intact organism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536 · cited 1×
“For example, in vertebrates, MDR1/Pgp overexpression specifically promotes chemotheraptic drug resistance in cancer cells (Gottesman et al., 2002).”
BackgroundThe Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · cited 5×
“Chemical protection of the brain is a complex process involving many overlapping physiologic systems and thousands of genes (Abbott, 2005; Sarkadi et al., 2006; Zlokovic, 2008).”
BackgroundInfluentialThe blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917 · cited 2×
“Although in vivo and in vitro BBB models have confirmed the importance of these two components (Schinkel et al., 1997; Nitta et al., 2003), substantial limitations hinder progress (Garberg et al.”
BackgroundStrategies to advance translational research into brain barriers
Neuwelt, E., Abbott, N. J., Abrey, L., Banks, W. A., Blakley, B., Davis, T., Engelhardt, B., Grammas, P., Nedergaard, M., Nutt, J., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70326-5 · Cited by 474
The rat blood-brain barrier transcriptome
Enerson, B. E., & Drewes, L. R. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600249 · Cited by 205
Research works printed but not linked: 42
- 10.1007/s10571-004-1374-y · DOI · Paper page
- 10.1124/dmd.105.006999 · DOI
- 10.1016/j.cell.2005.07.029 · DOI · Paper page
- 10.1016/j.nbd.2003.12.016 · DOI · Paper page
- 10.1385/CBB:46:1:65 · DOI
- 10.1016/j.ydbio.2008.03.007 · DOI
- Bosch, 1996, Expression of Drosophila melanogaster P-glycoproteins is associated with ATP channel activity, Am J Physiol, 271, C1527, 10.1152/ajpcell.1996.271.5.C1527 · doi:10.1152/ajpcell.1996.271.5.c1527
- Brand, 1993, Targeted gene expression as a means of altering cell fates and generating dominant phenotypes, Development, 118, 401, 10.1242/dev.118.2.401 · DOI · Paper page
- 10.1016/j.drudis.2006.07.006 · DOI
- 10.1146/annurev.ento.45.1.151 · DOI · Paper page
- 10.1093/jnci/85.8.632 · DOI · Paper page
- 10.1016/j.cell.2005.09.017 · DOI
- 10.1146/annurev.genom.6.080604.162122 · DOI · Paper page
- 10.1101/gr.GR-1649R · DOI · Paper page
- 10.1006/abio.1995.1469 · doi:10.1006/abio.1995.1469
- 10.1038/nature05954 · DOI · Paper page
- 10.1023/B:CEMN.0000022776.47302.ce · DOI
- 10.1242/jeb.002691 · doi:10.1242/jeb.002691
- 10.1002/cne.903330214 · doi:10.1002/cne.903330214
- 10.1016/S0896-6273(03)00289-7 · DOI · Paper page
- 10.1016/j.tiv.2004.06.011 · DOI · Paper page
- 10.1006/geno.1993.1286 · doi:10.1006/geno.1993.1286
- 10.1038/316820a0 · DOI · Paper page
- 10.1016/j.pneurobio.2005.04.006 · DOI · Paper page
- 10.1602/neurorx.2.1.86 · DOI · Paper page
- Nag S (2003) The blood-brain barrier (Humana, Totowa, NJ). · DOI
- 10.1385/MB:30:1:057 · DOI · Paper page
- 10.1016/j.ydbio.2005.04.024 · DOI · Paper page
- 10.1038/316817a0 · DOI · Paper page
- 10.1152/physrev.00037.2005 · DOI · Paper page
- 10.1006/scbi.1997.0068 · DOI · Paper page
- 10.1016/S0169-409X(98)00085-4 · DOI · Paper page
- 10.1073/pnas.94.8.4028 · DOI · Paper page
- 10.1016/j.cell.2005.08.037 · DOI · Paper page
- 10.1523/JNEUROSCI.4367-07.2008 · DOI · Paper page
- 10.1242/jeb.000125 · DOI
- 10.1006/dbio.1994.1054 · DOI · Paper page
- Treherne JE Pichon Y (1972) The insect blood–brain barrier (Academic, London). · DOI
- 10.1073/pnas.96.24.13679 · doi:10.1073/pnas.96.24.13679
- Wu, 1991, Isolation and characterization of Drosophila multidrug resistance gene homologs, Mol Cell Biol, 11, 3940
- 10.1016/j.ceb.2004.07.008 · DOI
- 10.1152/physiolgenomics.00018.2007 · doi:10.1152/physiolgenomics.00018.2007
Cited by
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657
Pandey, U. B., & Nichols, C. D. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003293 · Cited by 1,136
Crossing the blood-brain barrier with nanoparticles
Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837
“The BBB formed by the brain microvascular system is a membrane barrier that separates blood from the extracellular fluid of brain in the central nervous system (CNS) of most vertebrates including amphibians, reptiles, birds, and mammals [1,2].”
BackgroundDermauw, W., & Van Leeuwen, T. (2014) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2013.11.001 · Cited by 631
A Circadian Clock in the Blood-Brain Barrier Regulates Xenobiotic Efflux
Zhang, S. L., Yue, Z., Arnold, D. M., Artiushin, G., & Sehgal, A. (2018) · Cell · doi:10.1016/j.cell.2018.02.017 · Cited by 253
Metadata
- Authors
- Mayer, F., Mayer, N., Chinn, L., Pinsonneault, R. L., Kroetz, D., & Bainton, R. J.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-03-18
- Volume
- 29
- Issue
- 11
- Pages
- 3538-3550
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2088910052
- Cited by
- 182
- References
- 6
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.